Human single-stranded DNA protein 1 (hSSB1): a prognostic factor and target for non-small cell lung cancer (NSCLC) treatment

被引：0
|
作者：
Boucher, D. [1 ,2 ]
Ashton, N. [1 ,2 ]
Suraweera, A. [1 ,2 ]
Burgess, J. [1 ,2 ]
Bolderson, E. [1 ,2 ]
Barr, M. [3 ]
Gray, S. [3 ]
Gately, K. [3 ]
Adams, M. [1 ,2 ]
Croft, L. [1 ,2 ]
Richard, D. [1 ,2 ]
O'Byrne, K. [1 ,2 ]
机构：
[1] Queensland Univ Technol, Brisbane, Qld, Australia
[2] Translat Res Inst, Brisbane, Qld, Australia
[3] Trinity Coll Dublin, Thorac Oncol Res Grp, Dublin, Ireland
来源：
LUNG CANCER | 2019年 / 127卷
关键词：
D O I：
10.1016/S0169-5002(19)30084-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
40
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [41] Evaluation of Circulating Tumoral Microemboli (CTM) as a Prognostic Factor in Non-Small Cell Lung Cancer (NSCLC)
    Corassa, Marcelo
    Fanelli, Marcello
    Dettino, Aldo
    Tariki, Milena
    Abdallah, Emne
    Braun, Alexcia
    De Lima, Vladmir Cordeiro
    Freitas, Helano
    Chinen, Ludmilla
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S786 - S786
  • [42] Neutrophil Lymphocyte Ratio as a Prognostic Factor in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
    Richardet, Eduardo
    Richardet, M.
    Molina, M.
    Magi, I.
    Peruchin, V.
    Perea, P.
    Tello, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S12 - S12
  • [43] SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer
    Burgess, Joshua T.
    Bolderson, Emma
    Adams, Mark N.
    Duijf, Pascal H. G.
    Zhang, Shu-Dong
    Gray, Steven G.
    Wright, Gavin
    Richard, Derek J.
    O'Byrne, Kenneth J.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [44] Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer
    Mary-Clare Cathcart
    Kathy Gately
    Robert Cummins
    Elaine Kay
    Kenneth J O'Byrne
    Graham P Pidgeon
    Molecular Cancer, 10
  • [45] Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer
    Cathcart, Mary-Clare
    Gately, Kathy
    Cummins, Robert
    Kay, Elaine
    O'Byrne, Kenneth J.
    Pidgeon, Graham P.
    MOLECULAR CANCER, 2011, 10
  • [46] Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC)
    Schulze, Arik Bernard
    Schmidt, Lars Henning
    Kuemmel, Andreas
    Baie, Lara
    Albers, Christoph
    Faldum, Andreas
    Goerlich, Dennis
    Wiewrodt, Rainer
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [47] The transcription factor BCL6 is a rational target in non-small cell lung cancer (NSCLC)
    Marullo, Rossella
    Ahn, Haelee
    Cardenas, Mariano
    Melnick, Ari
    Xue, Fengtian
    Cerchietti, Leandro
    CANCER RESEARCH, 2016, 76
  • [48] Smoking and prognostic factors in advanced non-small cell lung cancer (NSCLC)
    Altug, S.
    Li, C.
    Marek, M.
    Guclu, S.
    Kim, Y.
    Meshref, M.
    Qin, S.
    Krejcy, K.
    Reece, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Cell proliferation markets as prognostic indicators in non-small cell lung cancer (NSCLC).
    Williams, SS
    Tran, TA
    Sheehan, CE
    Ross, JS
    MODERN PATHOLOGY, 1998, 11 (01) : 181A - 181A
  • [50] Lung cancer exosome specific protein 1(LESP-1) as a potential factor for diagnosis and treatment of non-small cell lung cancer.
    Kim, Hyun Koo
    Jeong, Hyesun
    Choi, Byeong Hyeon
    Quan, Yu Hua
    Rho, Jiyun
    Park, Ji-Ho
    Park, Yong
    Choi, Yeonho
    Han, Kook Nam
    Choi, Young Ho
    Hong, Sunghoi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345